Fosun Pharma to Divest 5% Stake in Gland Pharma via Rs 2,279 Crore Block Deal
Fosun Pharma Industrial, promoter of Gland Pharma, plans to divest a 5% stake worth approximately Rs 2,279.5 crore through a block deal at a floor price of Rs 2,763 per share, representing up to a 5% discount to the current market price. Fosun holds a 51.77% stake as of June 30, 2026. Gland Pharma recently reported a 47% year-on-year profit increase for Q1FY27 and received zero Form 483 observations from a USFDA inspection of its Visakhapatnam facilities. A 12-month lock-up will apply to further share sales.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 42/100.
Outlets measured: economictimes, economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 3 Sept, 03:53 pm. Other outlets followed.